Buscar resultados de ensayos clínicos
Malignant Peripheral Nerve Sheath Tumor - 25 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors Condición: Malignant Peripheral Nerve Sheath Tumors Fecha: 2017-04-13 |
Terminated |
Nombre del estudio: Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors Condición: Malignant Peripheral Nerve Sheath Tumors Fecha: 2007-01-25 Intervenciones: Drug: imatinib mesylate |
Recruiting |
Nombre del estudio: A Study of Pembrolizumab in Patients With Malignant Peripheral Nerve Sheath Tumor (MPNST), Not Eligible for Curative Surgery Condición: Malignant Peripheral Nerve Sheath Tumour (MPNST) Fecha: 2016-02-04 Intervenciones: Drug: Pembrolizumab Other Name: Keytruda |
Recruiting |
Nombre del estudio: PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors Condición:
Fecha: 2015-10-21 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: SARC023: Ganetespib and Sirolimos in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors) Condición:
Fecha: 2013-11-25 Intervenciones: |
Recruiting |
Nombre del estudio: Vaccine Therapy in Treating Patients With Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery Condición:
|
Active, not recruiting |
Nombre del estudio: SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors Condición:
|
Active, not recruiting |
Nombre del estudio: Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma Condición:
|
Completed |
Nombre del estudio: S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor Condición: Sarcoma Fecha: 2003-09-10 Intervenciones: Drug: erlotinib hydrochloride 150 mg per day, daily until disease progression |
Completed |
Nombre del estudio: Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors Condición:
Fecha: 2006-03-15 Intervenciones:
|